Literature DB >> 11030069

Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.

H A Reinders-Messelink1, T W Van Weerden, J M Fock, C E Gidding, H M Vingerhoets, M M Schoemaker, L N Göeken, J P Bökkerink, W A Kamps.   

Abstract

Neurophysiological functioning was studied prospectively in children treated for acute lymphoblastic leukaemia with a low dose vincristine regime (8 x 1.5 mg/m2/dose), to obtain more insight into vincristine neuropathy. A WHO neurotoxicity score was estimated and vibration sense and electrophysiological measurements were taken at standardized times during vincristine treatment. The WHO neurotoxicity score showed decreased or disappearance of Achilles tendon reflexes, and mild sensory disturbances, but a grade 3-4 neurotoxicity was not demonstrated by any of the children. Vibration perception thresholds increased progressively during treatment and amplitudes of action potentials of peroneal and sensory ulnar and median nerves decreased, whereas nerve conduction velocities stayed unchanged. Both vibration perception thresholds and the electrophysiological findings hardly exceeded the limits of normality. We conclude that children treated for acute lymphoblastic leukaemia with a low dose vincristine regimen have mild axonal neuropathy which may be responsible for the motor problems in these children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030069     DOI: 10.1053/ejpn.1999.0310

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  9 in total

1.  Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review.

Authors:  Ellen M Lavoie Smith; Clare Kuisell; Grace A Kanzawa-Lee; Celia M Bridges; Paola Alberti; Guido Cavaletti; Rima Saad; Susanna Park
Journal:  Lancet Haematol       Date:  2020-05       Impact factor: 18.959

Review 2.  Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.

Authors:  Kirsten K Ness; Saro H Armenian; Nina Kadan-Lottick; James G Gurney
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

3.  Physical activity among adult survivors of childhood lower-extremity sarcoma.

Authors:  Meredith A Wampler; Mary Lou Galantino; Sujuan Huang; Laura S Gilchrist; Victoria G Marchese; G Stephen Morris; David A Scalzitti; Melissa M Hudson; Kevin C Oeffinger; Marilyn Stovall; Wendy M Leisenring; Gregory T Armstrong; Leslie L Robison; Kirsten K Ness
Journal:  J Cancer Surviv       Date:  2011-06-18       Impact factor: 4.442

Review 4.  Peripheral neuropathy in children and adolescents treated for cancer.

Authors:  Kari L Bjornard; Laura S Gilchrist; Hiroto Inaba; Barthelemy Diouf; Marilyn J Hockenberry; Nina S Kadan-Lottick; Daniel C Bowers; M Eileen Dolan; Nicole J Ullrich; William E Evans; Kirsten K Ness
Journal:  Lancet Child Adolesc Health       Date:  2018-09-01

5.  Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.

Authors:  Stefanie Geisler; Ryan A Doan; Amy Strickland; Xin Huang; Jeffrey Milbrandt; Aaron DiAntonio
Journal:  Brain       Date:  2016-10-25       Impact factor: 13.501

6.  Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses.

Authors:  Kirsten K Ness; Melissa M Hudson; Ching-Hon Pui; Daniel M Green; Kevin R Krull; Tseng T Huang; Leslie L Robison; E Brannon Morris
Journal:  Cancer       Date:  2011-07-15       Impact factor: 6.860

7.  Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer.

Authors:  Stephen Sands; Elena J Ladas; Kara M Kelly; Michael Weiner; Meiko Lin; Deborah Hughes Ndao; Amie Dave; Linda T Vahdat; Julia Glade Bender
Journal:  Support Care Cancer       Date:  2016-11-09       Impact factor: 3.603

8.  Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia.

Authors:  Sindhu Ramchandren; Marcia Leonard; Rajen J Mody; Janet E Donohue; Judith Moyer; Raymond Hutchinson; James G Gurney
Journal:  J Peripher Nerv Syst       Date:  2009-09       Impact factor: 3.494

9.  Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric-modified Total Neuropathy Score.

Authors:  S M Schouten; M E van de Velde; G J L Kaspers; L B Mokkink; I M van der Sluis; C van den Bos; A Hartman; F C H Abbink; M H van den Berg
Journal:  Support Care Cancer       Date:  2019-11-16       Impact factor: 3.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.